Gilead Sciences (GILD)

EBITDA Margin

4.38%

TTM · Period ending:

GILD logo

GILD EBITDA Margin

Latest reported4.38%
GILD TTM EBITDA Margin (-306.67% → 4.38%)
High-resolution chart · PNG

GILD ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Gilead Sciences EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
4.3801%
47.1413%
46.1329%
47.002%
38.0154%
36.8275%
15.4245%
13.849%
18.9512%
17.4287%
38.7092%
39.0215%
38.8576%
38.4979%
32.4475%
28.0034%
31.3429%
32.5641%
41.4906%
44.7748%
35.7009%
17.7359%
16.7402%
17.795%
8.1131%
31.6473%
33.6719%
29.9396%
48.6917%
47.4373%
46.5721%
51.5866%
53.744%
58.4893%
61.0296%
64.0148%
63.7532%
63.1456%
63.2412%
65.5149%
67.2979%
69.4266%
71.8312%
70.3888%
68.381%
68.085%
65.5612%
62.7996%
60.0847%
51.4268%
43.3847%
44.3098%
44.7595%
45.3701%
43.8144%
43.3337%
44.5748%
45.6912%
49.5941%
50.2102%
51.023%
51.9639%
53.9409%
56.5089%
56.2382%
55.1071%
53.9774%
53.6709%
53.1309%
53.603%
53.879%
52.0505%
52.5378%
53.0151%
52.3821%
54.2521%
55.0697%
55.6715%
55.6016%
56.9953%
56.2008%
56.7608%
56.5486%
52.8231%
52.7404%
50.8634%
49.5309%
47.4747%
45.1106%
43.627%
40.4191%
39.1496%
36.4161%
28.6589%
20.445%
9.4998%
-10.9614%
-34.2938%
-45.3431%
-46.6919%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.